Eiger BioPharmaceuticals, Inc.
11
Stacey G Jernigan
04/01/2024
04/29/2025
Yes
v
| SEALEDEXH, SealedDocument, REFORM, COMPLEX, jntadmn, LEAD, ClaimsAgent, EXHIBITS |
Assigned to: Chief Bankruptcy Jud Stacey G Jernigan Chapter 11 Voluntary Asset |
|
Debtor Eiger BioPharmaceuticals, Inc.
c/o Douglas Staut, CRO 2100 Ross Avenue Dallas, TX 75201 SANTA CLARA-CA Tax ID / EIN: 33-0971591 |
represented by |
Thomas Robert Califano
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-5575 Fax : 212-839-5599 Email: tom.califano@sidley.com Veronica A. Courtney
Sidley Austin LLP 1000 Louisiana Street Ste 5900 Houston, TX 77002 713-495-4572 Fax : 713-495-7799 Email: vcourtney@sidley.com William E Curtin
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6745 Fax : 212-839-5599 Email: wcurtin@sidley.com Nathan Elner
Sidley Austin LLP 2021 McKinney Avenue Suite 2000 Dallas, TX 75201 212-839-5300 Email: nelner@sidley.com John Joseph Kuster
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-7336 Email: jkuster@sidley.com Jon Muenz
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-5901 Fax : 212-839-5599 Email: jmuenz@sidley.com Patrick J. Neligan, Jr.
Neligan LLP 4851 LBJ Freeway Suite 700 Dallas, TX 75244 214-912-9861 Email: pneligan@neliganlaw.com Charles Martin Persons, Jr.
Sidley Austin LLP 2020 McKinney Avenue, Suite 2000 Dallas, TX 75210 (214) 981-3300 Fax : (214) 981-3400 Email: charlespersons@paulhastings.com TERMINATED: 09/24/2024 Andrew J. Townsell
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-6793 Email: andrew.townsell@sidley.com Anne G. Wallice
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6021 Email: anne.wallice@sidley.com |
U.S. Trustee United States Trustee
1100 Commerce Street Room 976 Dallas, TX 75202 214-767-8967 |
represented by |
Elizabeth Ziegler Young
U.S. Trustee Office 1100 Commerce Street, Room 976 Dallas, TX 75242 (214) 767-8967 Fax : (214) 767-8971 Email: elizabeth.a.young@usdoj.gov |
Creditor Committee Official Unsecured Creditors Committee
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-855-7500 |
represented by |
Shira A. Baratz
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: sbarttz@melandbudwick.com Thomas Daniel Berghman
Munsch Hardt Kopf & Harr PC 500 N Akard Street, Suite 3800 Dallas, TX 75201-6659 (214) 855-7554 Fax : (214) 978-4346 Email: tberghman@munsch.com Michael S. Budwick
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mbudwick@melandbudwick.com Daniel N. Gonzalez
Meland Budwick, PA 200 S. Biscayne Boulevard, Suite 3200 Miami, FL 33131 (305) 358-6363 Fax : (305) 358-1221 Email: dgonzalez@melandbudwick.com Meaghan E. Murphy
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mmurphy@melandbudwick.com Garrick Chase Smith
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-740-5110 Fax : 214-855-7584 Email: gsmith@munsch.com |
| Date Filed | # | Docket Text |
|---|---|---|
| 04/29/2025 | 851 | Request for transcript regarding a hearing held on 4/29/2025. The requested turn-around time is daily filed by Interested Party Progeria Research Foundation. (Crozier, Jennifer) |
| 04/29/2025 | 850 | Request for transcript regarding a hearing held on 4/29/2025. The requested turn-around time is daily filed by Interested Party Sentynl Therapeutics, Inc.. (Ray, Hugh) |
| 04/29/2025 | 849 | Request for transcript regarding a hearing held on 4/29/2025. The requested turn-around time is daily filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. (Venus, S.) |
| 04/29/2025 | 848 | Request for transcript regarding a hearing held on 4/29/2025. The requested turn-around time is daily filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.. (Brookner, Jason) |
| 04/28/2025 | 847 | Order granting motion for order authorizing remote testimony by declarant at hearing on expedited motion for interim equitable relief (related document # [837]) Entered on 4/28/2025. (Rielly, Bill) |
| 04/28/2025 | 846 | Witness and Exhibit List for Hearings Scheduled on April 29, 2025 filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc. (RE: related document(s)[834] Motion for preliminary injunctionSentynl Therapeutics, Inc.'s Expedited Motion for Interim Equitable Relief (REDACTED), [835] SEALED Sentynl Therapeutics, Inc.'s Expedited Motion for Interim Equitable Relief per court order, [844] Emergency Motion to continue hearing on (related documents [834] Motion for preliminary injunction) EIT Pharma, Inc.'s Response to Expedited Motion for Interim Equitable Relief and Emergency Motion to Adjourn or Continue Hearing). (Attachments: # (1) Exhibit 1 # (2) Exhibit 2 # (3) Exhibit 3 # (4) Exhibit 4 # (5) Exhibit 5 # (6) Exhibit 6 # (7) Exhibit 7 # (8) Exhibit 8 # (9) Exhibit 9 # (10) Exhibit 10) (Brookner, Jason) |
| 04/28/2025 | 845 | Agenda for Hearing scheduled on 4/29/2025 /The Liquidating Trustee's Agenda for Hearing Scheduled for April 29, 2025 at 9:30 A.M. (Prevailing Central Time) filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[828] Order (I) Setting discovery and briefing schedule and (II) Related items (RE: related document(s)[729] Application for administrative expenses filed by Interested Party Sentynl Therapeutics, Inc., [777] Objection filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee, [779] Motion for Contempt filed by Interested Party Sentynl Therapeutics, Inc., [781] Motion to enforce filed by Interested Party Sentynl Therapeutics, Inc., [784] Sealed document per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee, [787] Motion to enforce filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.). Hearing to be held on 4/29/2025 at 09:30 AM Dallas Judge Jernigan Ctrm for [729] and for [787] and for [781] and for [779] and for [784] and for [777], Entered on 4/18/2025, [832] Motion to expunge (RE: related document(s)[729] Application for administrative expenses). Liquidating Trustee's Motion for Summary Judgment on Contested Matter, Expunging Administrative Claim of Sentynl Therapeutics, Inc. Filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (Attachments: # 1 Proposed Order) (Venus, S.), [834] Motion for preliminary injunctionSentynl Therapeutics, Inc.'s Expedited Motion for Interim Equitable Relief (REDACTED) Filed by Interested Party Sentynl Therapeutics, Inc. (Attachments: # 1 Exhibit A Proposed Order (redacted) # 2 Exhibit B Banaga Declaration (redacted))). (Venus, S.) |
| 04/25/2025 | 844 | Emergency Motion to continue hearing on (related documents [834] Motion for preliminary injunction) EIT Pharma, Inc.'s Response to Expedited Motion for Interim Equitable Relief and Emergency Motion to Adjourn or Continue Hearing Filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc. (Brookner, Jason) |
| 04/25/2025 | 843 | Response opposed to (related document(s): [834] Motion for preliminary injunctionSentynl Therapeutics, Inc.'s Expedited Motion for Interim Equitable Relief (REDACTED) filed by Interested Party Sentynl Therapeutics, Inc.) filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.. (Brookner, Jason) |
| 04/25/2025 | 842 | SEALED document regarding: Sentynl Therapeutics, Inc.'s Opposition to Liquidating Trustee's Motion for Summary Judgment on Contested Matter, Expunging Administrative Claim of Sentynl Therapeutics, Inc. per court order filed by Interested Party Sentynl Therapeutics, Inc. (RE: related document(s)[783] Order on motion to seal). (Attachments: # (1) Exhibit A Proposed Order # (2) Exhibit B Chart # (3) Exhibit C Hercz Declaration # (4) Exhibit D # (5) Exhibit E # (6) Exhibit F # (7) Exhibit G # (8) Exhibit H # (9) Exhibit I # (10) Exhibit J # (11) Exhibit K # (12) Exhibit L # (13) Exhibit M # (14) Exhibit N # (15) Exhibit O # (16) Exhibit P # (17) Exhibit Q # (18) Exhibit R # (19) Exhibit S # (20) Exhibit T # (21) Exhibit U) (Ray, Hugh) |